Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised

International Coalition of Medicines Regulatory Authorities (ICMRA)

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

EMA/HMA annual data forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 December 2025, 09:00 (CET) to 9 December 2025, 17:30 (CET)

Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga) chloride, Date of authorisation: 08/01/2026, Status: Authorised